Biocept, Inc. (BIOC) financial statements (2021 and earlier)

Company profile

Business Address 5810 NANCY RIDGE DR
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14932595
Cash and cash equivalents14932595
Receivables14421000
Inventory, net of allowances, customer advances and progress billings2110100
Inventory2110100
Deferred costs      1
Other undisclosed current assets200000(1)
Total current assets:3314646106
Noncurrent Assets
Finance lease, right-of-use asset22
Operating lease, right-of-use asset101
Property, plant and equipment2233211
Deferred costs      0
Other noncurrent assets0     0
Other undisclosed noncurrent assets      (0)
Total noncurrent assets:15433211
TOTAL ASSETS:4718978117
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12443222
Accounts payable8221111
Accrued liabilities3222111
Employee-related liabilities      1
Interest and dividends payable      0
Debt1212220
Derivative instruments and hedges, liabilities      0
Other undisclosed current liabilities   000(1)
Total current liabilities:12655431
Noncurrent Liabilities
Long-term debt and lease obligation111112310
Long-term debt, excluding current maturities    1310
Finance lease, liability11
Capital lease obligations11100
Operating lease, liability10 
Liabilities, other than long-term debt  00001
Deferred revenue and credits0001
Deferred rent credit  0
Other undisclosed noncurrent liabilities(10)   00(5)
Total noncurrent liabilities:11111345
Total liabilities:24766777
Stockholders' equity
Stockholders' equity attributable to parent24113114(0)
Common stock0000000
Additional paid in capital287257223197174159138
Accumulated deficit(264)(246)(220)(195)(174)(155)(138)
Total stockholders' equity:24113114(0)
TOTAL LIABILITIES AND EQUITY:4718978117

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues27635310
Revenue, net17   
Other income    00
Cost of revenue(21)(11)(10)(9)(7)(5)(2)
Gross profit:6(5)(7)(4)(4)(4)(2)
Operating expenses(22)(18)(17)(17)(14)(12)(12)
Other undisclosed operating income      0
Operating loss:(15)(23)(24)(21)(18)(16)(14)
Nonoperating expense(2)(2)(0)(0)(0)(1)(2)
Interest and debt expense(0)(0)(0)(0)(1)(1)(2)
Loss from continuing operations before equity method investments, income taxes:(18)(25)(25)(22)(19)(18)(18)
Other undisclosed income from continuing operations before income taxes0000112
Loss from continuing operations before income taxes:(18)(25)(25)(22)(18)(17)(16)
Income tax expense  (0)(0)(0)(0)(0)
Net loss attributable to parent:(18)(25)(25)(22)(18)(17)(16)
Other undisclosed net loss available to common stockholders, basic(0)(0)(1)    
Net loss available to common stockholders, diluted:(18)(25)(25)(22)(18)(17)(16)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(18)(25)(25)(22)(18)(17)(16)
Comprehensive loss, net of tax, attributable to parent:(18)(25)(25)(22)(18)(17)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: